(Q35282583)

7 August 2017

Atenolol versus losartan in children and young adults with Marfan's syndrome (English)

1 reference

7 August 2017

1 reference

Julie De Backer

14

0 references

Bart L Loeys

object named as

Bart L Loeys

20

0 references

Timothy J Bradley

object named as

Timothy J Bradley

Pediatric Heart Network Investigators

5

0 references

Bruce D. Gelb

0 references

34

object named as

Pediatric Heart Network Investigators

1 reference

7 August 2017

3

Lynn A Sleeper

1 reference

7 August 2017

6

Steven D Colan

1 reference

7 August 2017

33

Lynn Mahony

1 reference

7 August 2017

10

Andrew M Atz

1 reference

7 August 2017

16

Paul D Grossfeld

1 reference

7 August 2017

Ronald V Lacro

1

1 reference

7 August 2017

Harry C Dietz

2

1 reference

7 August 2017

Anji T Yetman

4

1 reference

7 August 2017

Gail D Pearson

7

1 reference

7 August 2017

E Seda Selamet Tierney

8

1 reference

7 August 2017

Jami C Levine

9

1 reference

7 August 2017

D Woodrow Benson

11

1 reference

7 August 2017

Alan C Braverman

12

1 reference

7 August 2017

Shan Chen

13

1 reference

7 August 2017

Bruce D Gelb

15

1 reference

7 August 2017

Gloria L Klein

17

1 reference

7 August 2017

Wyman W Lai

18

1 reference

7 August 2017

Aimee Liou

19

1 reference

7 August 2017

Larry W Markham

21

1 reference

7 August 2017

Aaron K Olson

22

1 reference

7 August 2017

Stephen M Paridon

23

1 reference

7 August 2017

Victoria L Pemberton

24

1 reference

7 August 2017

Mary Ella Pierpont

25

1 reference

7 August 2017

Reed E Pyeritz

26

1 reference

7 August 2017

Elizabeth Radojewski

27

1 reference

7 August 2017

Mary J Roman

28

1 reference

7 August 2017

Angela M Sharkey

29

1 reference

7 August 2017

Mario P Stylianou

30

1 reference

7 August 2017

Stephanie Burns Wechsler

31

1 reference

7 August 2017

Luciana T Young

32

1 reference

7 August 2017

language of work or name

English

0 references

publication date

18 November 2014

1 reference

The New England Journal of Medicine

7 August 2017

1 reference

7 August 2017

371

1 reference

7 August 2017

22

1 reference

7 August 2017

2061-2071

1 reference

Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Lessons on the pathogenesis of aneurysm from heritable conditions

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Treatment of aortic disease in patients with Marfan syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Revised diagnostic criteria for the Marfan syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

The randomization and stratification of patients to clinical trials

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Usefulness of losartan on the size of the ascending aorta in an unselected cohort of children, adolescents, and young adults with Marfan syndrome

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

[Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome].

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

The Ghent Marfan Trial--a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386623

Growth and maturation in Marfan syndrome

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25405392

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-β1

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25405392

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMOA1404731

1 reference

7 August 2017

1 reference

7 August 2017

1 reference